Oppenheimer Cuts PT on Zogenix (ZGNX), Still Outperform, Thesis Intact
Tweet Send to a Friend
Analysts at Oppenheimer reiterated their Outperform rating on Zogenix, Inc. (NASDAQ: ZGNX) but cut their price target of $3.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
